tiprankstipranks
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market

Skye Bioscience (SKYE) Financial Statements

114 Followers

Skye Bioscience Financial Overview

Skye Bioscience's market cap is currently ―. The company's EPS TTM is $-5.695; its P/E ratio is -2.85; Skye Bioscience is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
Ebit$ -3.99M$ -24.67M$ -2.92M$ -4.79M$ -9.28M
Ebitda$ -3.73M$ -24.54M$ -2.89M$ -4.76M$ -9.24M
Net Income Common Stockholders$ -5.03M$ -24.98M$ -3.11M$ -5.17M$ -9.89M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 1.26M$ 5.13M$ 558.03K$ 2.67M$ 1.25M
Total Assets$ 11.94M$ 15.60M$ 2.24M$ 4.59M$ 9.02M
Total Debt$ 4.62M$ 4.43M$ 364.65K$ 239.89K$ 1.93M
Net Debt$ 3.36M$ -699.90K$ -193.38K$ -2.43M$ 677.97K
Total Liabilities$ 14.07M$ 13.91M$ 10.03M$ 9.37M$ 12.12M
Stockholders Equity$ -2.13M$ 1.70M$ -7.79M$ -4.78M$ -3.01M
Cash Flow-
Free Cash Flow$ -9.38M$ -4.06M$ -1.99M$ 1.47M-
Operating Cash Flow$ -3.84M$ -4.05M$ -1.99M$ -4.06M-
Investing Cash Flow$ -7.02K$ 1.07M-$ 5.53M-
Financing Cash Flow$ -22.65K$ 16.63M$ -123.41K$ -45.31K-
Currency in USD

Skye Bioscience Earnings and Revenue History

Skye Bioscience Debt to Assets

Skye Bioscience Cash Flow

Skye Bioscience Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis